These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 28863123
1. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation. Uslu-Beşli L, Kabasakal L, Sağer S, Cicik E, Asa S, Sönmezoğlu K. Nucl Med Commun; 2017 Nov; 38(11):964-970. PubMed ID: 28863123 [Abstract] [Full Text] [Related]
2. Orbital positron emission tomography/computed tomography (PET/CT) imaging findings in Graves ophthalmopathy. García-Rojas L, Adame-Ocampo G, Mendoza-Vázquez G, Alexánderson E, Tovilla-Canales JL. BMC Res Notes; 2013 Sep 04; 6():353. PubMed ID: 24007404 [Abstract] [Full Text] [Related]
3. [F-qi-FDG PET of the thyroid gland in Graves' disease]. Börner AR, Voth E, Wienhard K, Wagner R, Schicha H. Nuklearmedizin; 1998 Sep 04; 37(7):227-33. PubMed ID: 9830612 [Abstract] [Full Text] [Related]
4. Quantitative CT of the orbit in Graves' disease. Ozgen A, Alp MN, Ariyürek M, Tütüncü NB, Can I, Günalp I. Br J Radiol; 1999 Aug 04; 72(860):757-62. PubMed ID: 10624341 [Abstract] [Full Text] [Related]
5. Elevated 18F-FDG uptake in skeletal muscles and thymus: a clue for the diagnosis of Graves' disease. Chen YK, Chen YL, Liao AC, Shen YY, Kao CH. Nucl Med Commun; 2004 Feb 04; 25(2):115-21. PubMed ID: 15154698 [Abstract] [Full Text] [Related]
8. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy. Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y. Am J Ophthalmol; 2003 Mar 04; 135(3):285-90. PubMed ID: 12614743 [Abstract] [Full Text] [Related]
11. 18 F-FDG-PET/MRI in patients with Graves' orbitopathy. Weber M, Deuschl C, Bechrakis N, Umutlu L, Antoch G, Eckstein A, Binse I, Oeverhaus M. Graefes Arch Clin Exp Ophthalmol; 2021 Oct 04; 259(10):3107-3117. PubMed ID: 34406498 [Abstract] [Full Text] [Related]
15. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy. Konuk O, Atasever T, Unal M, Ayvaz G, Yetkin I, Cakir N, Arslan M, Hasanreisoglu B. Thyroid; 2002 Jul 04; 12(7):603-8. PubMed ID: 12193305 [Abstract] [Full Text] [Related]
16. Graves' orbitopathy: current imaging procedures. Kirsch E, Hammer B, von Arx G. Swiss Med Wkly; 2009 Oct 31; 139(43-44):618-23. PubMed ID: 19950023 [Abstract] [Full Text] [Related]
17. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Trokel SL, Jakobiec FA. Ophthalmology; 1981 Jun 31; 88(6):553-64. PubMed ID: 6894976 [Abstract] [Full Text] [Related]
18. Diagnostic trinity: Graves' disease on F-18 FDG PET. Chen YK, Wang YF, Chiu JS. Clin Nucl Med; 2007 Oct 31; 32(10):816-7. PubMed ID: 17885368 [Abstract] [Full Text] [Related]
19. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy. Erdei A, Steiber Z, Molnar C, Berenyi E, Nagy EV. BMC Ophthalmol; 2018 Jan 12; 18(1):5. PubMed ID: 29329570 [Abstract] [Full Text] [Related]
20. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy. Kim JW, Han SH, Son BJ, Rim TH, Keum KC, Yoon JS. Graefes Arch Clin Exp Ophthalmol; 2016 May 12; 254(5):991-8. PubMed ID: 26876240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]